Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 115, Issue -, Pages 268-274Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2016.03.006
Keywords
Imidazoquinoxalines; IKK inhibitors; NF-kappa B
Categories
Funding
- French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]
Ask authors/readers for more resources
The inhibition of the NF-kappa B-dependent pathways by IKK inhibitors plays an important role in immunity, inflammation, and cancer. New imidazoquinoxalines tricyclic derivatives are prepared using microwave assistance and their biological activities as IKK inhibitors are described. Compounds 6a present a potent inhibition activity and selectivity for IKK2. Docking studies in the IKK2 binding site allowed identification of residues most likely to interact with theses inhibitors and explain their potent IKK2 inhibition activity and selectivity. (C) 2016 Elsevier Masson SAS. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available